TKTL1: The Metabolic Sensor Linking Cellular Metabolism and Proliferation

Recent research has revealed a remarkable link between how cells manage energy and nutrients and the timing of their division. At the center of this process is TKTL1, a key metabolic enzyme that functions as a sensor, monitoring the cell’s internal levels of ribose-5-phosphate (R5P), a critical molecule for building DNA and other essential cellular components.
The core finding of the study is that the availability of key metabolites, particularly R5P, regulates cell proliferation through a previously unrecognized molecular circuit. At the heart of this circuit lies TKTL1, already known for its role in the pentose phosphate pathway and in the metabolic reprogramming characteristic of cancer cells.
The research shows that R5P is not merely a structural metabolite but also serves as a metabolic status signal. When R5P levels drop, the cell interprets this as a high proliferative demand. In response, a molecular circuit involving TKTL1, CDH1, and VHL coordinates resource availability with cell cycle progression.
Specifically, TKTL1 functions as an R5P sensor, translating metabolic fluctuations into signals that trigger the degradation of CDH1, a key cell cycle regulator that normally restrains proliferation. When TKTL1 binds R5P, it promotes CDH1 degradation, effectively removing the G1 phase block and allowing the cell to enter S phase. With this regulatory brake released, the cell can proceed through division.
Although seemingly simple, this mechanism has profound biological implications: it directly links anabolic resource sufficiency with the decision to divide. The study also resolves a long-standing paradox: CDH1, traditionally considered halting proliferation, also functions as a metabolic driver, promoting both the Warburg effect and angiogenesis when dynamically regulated.
This duality is now explained by the interplay between TKTL1 and R5P: it is not the loss of CDH1 itself that drives tumor behaviour, but the way its activity is metabolically controlled. CDH1’s function is finely tuned by TKTL1 in accordance with the cell’s metabolic state, linking proliferation to nutrient availability.
The discovery opens new avenues for targeting cancer metabolism. Modulating TKTL1, either by altering its ability to bind R5P or its capacity to trigger CDH1 degradation, can disrupt the delicate balance between metabolism and proliferation, pushing tumour cells into irreversible metabolic stress.
This study reinforces the role of TKTL1 as a central node in cellular metabolism, integrating energetic, anabolic, and proliferative signals. TKTL1 emerges not merely as an enzyme of the pentose phosphate pathway but as a molecular decision-maker, determining when a cell can or must divide.
Conclusion: TKTL1 plays a central role in cancer metabolism. By sensing ribose-5-phosphate (R5P) levels and regulating CDH1, it links metabolic signals with cellular growth decisions, enabling tumor cells to adapt and thrive.
Targeting this metabolic “switch” offers a promising avenue for novel cancer therapies aimed at disrupting tumor growth and survival. TKTL1 is more than an enzyme, it acts as a molecular decision-maker, guiding when cells grow and divide, and providing new insight into the metabolism-driven mechanisms that underlie cancer progression.
Reference:
Mao, Y.-Z., Zhang, J.-J., et al. (2025). CDH1 Orchestrates Anabolic Events to Promote Cell Cycle Initiation. Advanced Science. https://doi.org/10.1002/advs.202507584
.